SCHEMBL6627062

SCHEMBL6627062

c1ccc(CN2CCN(c3[nH]nc4ccsc34)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.49
HTR3E A5X5Y0 2/20 0.49
HTR3B O95264 2/20 0.49
HTR2C P28335 2/20 0.49
HTR3A P46098 2/20 0.49
HTR3D Q70Z44 2/20 0.49
HTR3C Q8WXA8 2/20 0.49
MC4R P32245 1/20 0.49
HTR7 P34969 1/20 0.48
DRD4 P21917 4/20 0.48
SIGMAR1 Q99720 2/20 0.47
GAA P10253 1/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2953020 0.76 HTR3E (0.50) HTR1AHTR3EHTR3BHTR2CHTR3A
SCHEMBL2628934 0.71 HRH1 (0.57) HTR1AHTR3EHTR3BHTR2CHTR3A
SCHEMBL2961731 0.69 HTR3E (0.54) HTR1AHTR3EHTR3BHTR2CHTR3A
SCHEMBL576868 0.69 SIGMAR1 (1.00) MC4RDRD4SIGMAR1KMT2ALMNA
SCHEMBL1041303 0.69 SIGMAR1 (1.00) MC4RDRD4SIGMAR1KMT2ALMNA
SCHEMBL2489199 0.69 SIGMAR1 (1.00) MC4RDRD4SIGMAR1KMT2ALMNA
SCHEMBL1415730 0.69 SIGMAR1 (1.00) MC4RDRD4SIGMAR1KMT2ALMNA
SCHEMBL8188324 0.69 SIGMAR1 (1.00) MC4RDRD4SIGMAR1KMT2ALMNA
SCHEMBL242970 0.69 SIGMAR1 (1.00) MC4RDRD4SIGMAR1KMT2ALMNA
SCHEMBL7827209 0.68 SIGMAR1 (0.60) MC4RDRD4SIGMAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392676-A2 HETEROCYCLIC UREA DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS Aventis Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002066468-A2 HETEROCYCLIC UREA DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS AVENTIS PHARMACEUTICALS INC. (US) 2002-08-29 WO disclosed